1.82
price up icon10.30%   0.17
after-market Handel nachbörslich: 1.81 -0.01 -0.55%
loading

Citius Oncology Inc Aktie (CTOR) Neueste Nachrichten

pulisher
03:05 AM

What drives Citius Oncology Inc. stock priceConsistently exceptional gains - Autocar Professional

03:05 AM
pulisher
Jul 22, 2025

Is Citius Oncology Inc. a good long term investmentTriple-digit profit margins - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Citius Oncology Inc. Stock Analysis and ForecastFree Stock Market Query - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Citius Oncology Inc. stockFree Wealth Management Insights - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

Citius Oncology Announces Closing of $9.0 Million Public Offering - Eastern Progress

Jul 19, 2025
pulisher
Jul 18, 2025

Citius Oncology shares rise 1.31% after-hours after closing a $9.0 million public offering. - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Should I buy Citius Oncology Inc. stock before earningsShort Term High Return Strategy - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Citius Oncology Completes $9M Public Offering - TipRanks

Jul 18, 2025
pulisher
Jul 17, 2025

Citius Oncology launches $15M equity and warrant offering; shares down - MSN

Jul 17, 2025
pulisher
Jul 17, 2025

Citius Oncology closes $9 million public offering to support LYMPHIR - Investing.com Australia

Jul 17, 2025
pulisher
Jul 17, 2025

Citius Oncology closes $9 million public offering to support LYMPHIR By Investing.com - Investing.com India

Jul 17, 2025
pulisher
Jul 17, 2025

Citius Oncology Raises $9M in Public Offering for LYMPHIR Commercialization - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

Citius Oncology Announces Closing Of $9.0 Million Public Offering - Barchart.com

Jul 17, 2025
pulisher
Jul 17, 2025

Citius Oncology Announces Pricing Of $9M "Reasonable Best-Efforts" Public Offering Of 6,818,182 Shares Of Common Stock And Warrants To Purchase Shares Of Common Stock At A Public Offering Price Of $1.32 Per Share - 富途牛牛

Jul 17, 2025
pulisher
Jul 16, 2025

Citius Pharmaceuticals shares fall 1.34% after-hours following Citius Oncology's public offering. - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Citius Oncology’s Chances: Time to Invest? - StocksToTrade

Jul 16, 2025
pulisher
Jul 16, 2025

Citius Oncology Announces Pricing of $9.0 Million Public Offering - Finansavisen

Jul 16, 2025
pulisher
Jul 16, 2025

Citius Oncology Soars 35.06% on Distribution Deal - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Citius Oncology Soars 12.34% on Expanded Lymphir Distribution - AInvest

Jul 16, 2025
pulisher
Jul 15, 2025

Citius Oncology stock rises after expanding LYMPHIR distribution network - Investing.com

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Citius Oncology Inc. stock price move sharplySecure Your Capital Strategy - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Citius Oncology Inc. stock attracts strong analyst attentionEarly Breakout Tracker - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Cencora (COR) Partners With Citius Oncology For Immunotherapy Distribution Expansion - simplywall.st

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology Shares Climb Following Expansion of LYMPHIR Distribution Network - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology (CTOR): Is LYMPHIR's Launch Priced for Success? - AInvest

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology: Is A Lymphir Launch Coming Too Late? - Seeking Alpha

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Pharmaceuticals (CTXR) Surges on New Distribution Deal - GuruFocus

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology stock rises after expanding LYMPHIR distribution network By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

How Citius Oncology Inc. stock performs during market volatilityLow Risk Entry Points - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology Expands Lymphir Distribution With Cencora - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Cencora distribution deal boosts Citius shares - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology expands distribution network for LYMPHIR with Cencora - Investing.com Australia

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology expands distribution network for LYMPHIR with Cencora By Investing.com - Investing.com India

Jul 15, 2025
pulisher
Jul 15, 2025

Citius stock gains on Cencora distribution deal (CTXR:NASDAQ) - Seeking Alpha

Jul 15, 2025
pulisher
Jul 15, 2025

Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora - Finansavisen

Jul 15, 2025
$73.31
price up icon 1.34%
$15.02
price up icon 0.60%
$9.37
price up icon 1.41%
drug_manufacturers_specialty_generic RDY
$14.60
price up icon 1.32%
$133.66
price up icon 0.69%
$305.61
price up icon 2.59%
Kapitalisierung:     |  Volumen (24h):